Ana Rovira
Instituto de Salud Carlos III(ES)Centre for Biomedical Network Research on Rare Diseases(ES)Hospital Del Mar(ES)Municipal Institute for Medical Research(ES)Hospital del Mar Research Institute(ES)Centro de Investigación Biomédica en Red de Cáncer(ES)
Publications by Year
Research Areas
Cancer Cells and Metastasis, HER2/EGFR in Cancer Research, Lung Cancer Research Studies, Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations(2018)545 cited
- → Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer(2012)500 cited
- → Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer(2015)268 cited
- → Mechanism of Action of Anti-Her2 Monoclonal Antibodies: Scientific Update on Trastuzumab and 2c4(2003)217 cited
- → Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer(2011)177 cited
- → Interleukin 6, a Nuclear Factor-κB Target, Predicts Resistance to Docetaxel in Hormone-Independent Prostate Cancer and Nuclear Factor-κB Inhibition by PS-1145 Enhances Docetaxel Antitumor Activity(2006)